Northern Trust
NEPH icon

Northern Trust’s Nephros NEPH Stock Holding History

Northern Trust’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.3K Hold
10,828
– – ﹤0.01% 4298
2025
Q4 		$52.8K Buy
+10,828
New +$55.3K ﹤0.01% 4267

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Cornerstone Capital Palo Alto, California $1B AUM 21.47% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Northern Trust's NEPH Position: Q1 2026 in Review

Northern Trust held its Nephros (NEPH) position steady in Q1 2026 at 10,828 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4298.

Northern Trust first reported a position in NEPH in Q4 2025 and has held it in 2 quarters since. The position peaked at $52.8K in Q4 2025. 27 funds tracked by Wall St. Rank hold NEPH as of Q1 2026.

  • Northern Trust held 10,828 shares of Nephros worth $32.3K as of Q1 2026.
  • Northern Trust left its Nephros share count unchanged in Q1 2026.
  • Nephros made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4298 holding.
  • Northern Trust first reported a position in Nephros in Q4 2025 and has held it in 2 quarters since.
  • Northern Trust's Nephros position peaked at $52.8K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Nephros as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.